Volume 14, Number 10—October 2008
Research
Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
Table 4
Severity-specific underreporting for salmonellosis, campylobacteriosis, and STEC infections*
Condition/severity category | Symptom multiplier† (95% CrI) | No. reported cases in severity category, in hundreds (95% CrI) | No. cases in the community for every 100 reported‡ (95% CrI) |
---|---|---|---|
Salmonellosis | |||
With blood | |||
1–2 d | 11.39 (8.49–16.36) | 1 (0–3) | 12.7 (0.8–32.1) |
3–4 d | 2.82 (2.17–3.98) | 7 (5–10) | 19.9 (12.6–30.9) |
> 5 d | 1.81 (1.33–2.72) | 42 (37–47) | 76.6 (54.3–116.0) |
Without blood | |||
1–2 d | 143.29 (83.30–371.0) | 2 (1–4) | 282.6 (50.4–870.3) |
3–4 d | 13.06 (6.37–67.83) | 7 (5–10) | 91.8 (40.3–533.5) |
>5 d | 3.93 (2.10–11.92) | 41 (36–46) | 160.8 (85.8–513.8) |
Overall | 100 | 695 (399–1,643) | |
Campylobacteriosis | |||
With blood | |||
1–2 d | 12.40 (9.16–17.82) | 2(1–3) | 24.8 (16.3–38.6) |
3–4 d | 3.06 (2.32–4.33) | 8(6, 10) | 24.3 (15.8–36.9) |
>5 d | 1.97 (1.42–2.95) | 34 (31, 37) | 67.92 (48.5–106.3) |
Without blood | |||
1–2 d | 154.17 (89.31–397.59) | 3 (2–4) | 475.7 (250.6–1,234.3) |
3–4 d | 14.15 (6.80–73.32) | 10 (8–12) | 139.0 (68.7–739.7) |
>5 d | 4.25 (2.25–13.36) | 43 (40–46) | 183.4 (97.9–578.1) |
Overall | 100 | 1001 (664–2,251) | |
STEC in South Australia | |||
With blood | |||
1–2 d | 13.02 (9.50–18.37) | 0 | 0 |
3–4 d | 3.13 (2.36–4.45) | 18 (6–30) | 51.6 (16.2–101.2) |
>5 d | 2.02 (1.47–3.04) | 68 (50–87) | 123.5 (74.9–212.9) |
Without blood | |||
1–2 d | 157.18 (61.67–218.75) | 3 (1–5) | 432.5 (142.4–1,220.1) |
3–4 d | 14.35 (7.38–64.34) | 6(1–11) | 78.0 (13.6–400.1) |
>5 d | 4.31 (2.27–13.44) | 6 (1–11) | 2-3.0 (2.67–91.7) |
Overall | 13.02 (9.50–18.37) | 100 | 815 (330–7,514) |
*STEC, Shiga toxin–producing Esherichia coli.
†Number of cases in the community for every notification.
‡Product of previous 2 columns.